Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review.

There was a trend for a reduced cumulative incidence of grade II-IV aGVHD with MSC compared to placebo (30% vs 53%) but this did not reach statistical significance, neither in raw proportions nor in cumulative incidences, considering all grades or only grades II-IV aGVHD (Table 2 ).

also in 111,027 other papers